Li Ning Li
Direktor/Vorstandsmitglied bei HaploX Investment Holding Ltd.
Aktive Positionen von Li Ning Li
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Direktor/Vorstandsmitglied | 29.01.2023 | - |
Karriereverlauf von Li Ning Li
Ehemalige bekannte Positionen von Li Ning Li
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Grains Valley Venture Capital | Geschäftsführer | 01.01.2009 | 02.01.2009 |
Ausbildung von Li Ning Li
China Pharmaceutical University | Undergraduate Degree |
University of Cardiff | Graduate Degree |
Statistik
International
China | 3 |
Cayman Islands | 2 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Undergraduate Degree | 1 |
Sektoral
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Commercial Services |
Grains Valley Venture Capital |
- Börse
- Insiders
- Li Ning Li
- Erfahrung